A news website on Indian venture capital, private equity, mergers and acquisitions

Visit VC Circle

Biotech Firm GangaGen Gets $1.8M From ATEL Ventures

Posted on October 08, 2008

Bangalore, Canada and US-based biotechnology company GangaGen Inc has raised $1.8 million in second round of funding from ATEL Ventures, a San Francisco based venture fund. GangaGen is developing bacteriophage-based remedies for some of the bacterial infections, particularly the infections that are resistant to antibiotics. Phages are highly specific, naturally occurring agents that invade bacteria and destroy them. The first observation of phage was made in the Indian river Ganges from where the company owes its name. Some of the major issues it is addressing are contamination of meat ...

Original article link


venture fund